Recombinant Antibodies against Mycolactone
AbstractIn the past, it has proved challenging to generate antibodies against mycolactone, the primary lipidic toxin A of Mycobacterium ulcerans causing Buruli ulcer, due to its immunosuppressive properties. Here we show that in vitro display, comprising both phage and yeast display, can be used to select antibodies recognizing mycolactone from a large human naïve phage antibody library. Ten different antibodies were isolated, and hundreds more identified by next generation sequencing. These results indicate the value of in vitro display methods to generate antibodies against difficult antigenic targets such as toxins, which cannot be used for immunization unless inactivated by structural modification. The possibility to easily generate anti-mycolactone antibodies is an exciting prospect for the development of rapid and simple diagnostic/detection methods. View Full-Text
- Supplementary File 1:
ZIP-Document (ZIP, 19 KB)
Share & Cite This Article
Naranjo, L.; Ferrara, F.; Blanchard, N.; Demangel, C.; D’Angelo, S.; Erasmus, M.F.; Teixeira, A.A.; Bradbury, A.R. Recombinant Antibodies against Mycolactone. Toxins 2019, 11, 346.
Naranjo L, Ferrara F, Blanchard N, Demangel C, D’Angelo S, Erasmus MF, Teixeira AA, Bradbury AR. Recombinant Antibodies against Mycolactone. Toxins. 2019; 11(6):346.Chicago/Turabian Style
Naranjo, Leslie; Ferrara, Fortunato; Blanchard, Nicolas; Demangel, Caroline; D’Angelo, Sara; Erasmus, M. F.; Teixeira, Andre A.; Bradbury, Andrew R. 2019. "Recombinant Antibodies against Mycolactone." Toxins 11, no. 6: 346.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.